InterveXion Therapeutics | Little Rock Pharmaceutical Company
Call Us: 501.554.2377
Home
About Us
Overview
Management Team and Founders
Financial Conflict of Interest
Research & Development
Anti-Methamphetamine Products
Intellectual Property
Facilities
Methamphetamine Use Statistics
Publications
Contact Us
News
Contact Us
Mailing Address:
4301 W. Markham #831
Little Rock, Arkansas 72205
Shipping Address:
401 S. Cedar St.
Little Rock, Arkansas 72205
Phone:
501.554.2377
Please use the form below to send us an email:
Name
(required, at least 2 characters)
E-Mail
(required)
Phone
(optional)
ext.
Your comment
(required)
News
InterveXion Completes Planned Dosing in Phase 1a Study of ch-mAb7F9
LITTLE ROCK – InterveXion Therapeutics LLC and the University of Arkansas for Medical...
A Vaccine to Curb Addicts’ Highs
Chief Scientific Officer, Mike Owens, Ph.D., was quoted in the Wall Street Journal...
First Human Subject Dosed in Phase 1a Study of ch-mAb7F9
The first subjects have been successfully dosed in InterveXion’s Phase 1a clinical safety...